Related Experiment Video
Updated: May 11, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Cerebrovascular complications in children with sickle cell disease
1Department of Pediatrics, Hôpital Necker Enfants Malades and Sickle Cell Reference Center, Paris, France.
Insights
Children with sickle cell disease (HbSS) face high stroke risk. Annual Transcranial Doppler (TCD) screening and monthly transfusions can prevent strokes in high-risk children.
Area of Science:
- Pediatric Neurology
- Hematology
- Vascular Medicine
Background:
- Sickle cell disease (HbSS) historically led to significant mortality and morbidity from cerebrovascular accidents in children.
- Children with HbSS have an 11% risk of stroke before age 20, with peak incidence of ischemic stroke between 2-5 years and hemorrhagic stroke between 20-29 years.
- Vessel occlusion in sickle cell disease involves intimal proliferation, inflammation, cell adhesion, hypercoagulability, and dysregulated vascular tone, potentially causing silent infarcts and cognitive decline.
Purpose of the Study:
- To highlight the effectiveness of Transcranial Doppler (TCD) ultrasonography in identifying children at high risk for stroke.
- To present evidence supporting stroke prevention strategies in pediatric sickle cell disease.
- To outline current recommendations for screening and treatment of cerebral vasculopathy in children with sickle cell disease.
Main Methods:
- Utilized Transcranial Doppler (TCD) ultrasonography for early detection of high-risk children.
- Reviewed findings from a randomized study on stroke prevention through monthly transfusions in children with abnormal TCD results.
- Examined the efficacy of chronic transfusion in reducing stroke recurrence and considered hematopoietic stem cell transplant as a treatment option.
Main Results:
- Transcranial Doppler (TCD) ultrasonography effectively identifies children at high risk for clinical strokes.
- Monthly transfusions significantly reduced the incidence of first-time strokes in children with abnormal TCD findings.
- Chronic transfusion therapy greatly reduces, but does not eliminate, the risk of stroke recurrence after a first event.
Conclusions:
- Annual TCD screening for children aged 2-16 years is recommended, with monthly transfusions for those identified as high-risk.
- Hematopoietic stem cell transplant is a viable option for children with cerebral vasculopathy and an HLA-identical sibling.
- Early detection and intervention are crucial for managing cerebrovascular complications in pediatric sickle cell disease.
Abstract:
Cerebrovascular accidents were until recently responsible for much mortality and morbidity in children with sickle cell disease; the likelihood of a child with HbSS having a stroke was 11% before age 20 years, with a peak incidence of ischemic stroke between 2 and 5 years of age, and of hemorrhagic strokes between 20 and 29 years of age. Vessels occlusion is likely initiated by intimal proliferation and amplified by inflammation, excessive adhesion of cells to activated endothelium, hypercoagulable state, and vascular tone dysregulation. Silent infarcts may occur and are associated with decreased cognitive functions. Transcranial Doppler ultrasonography (TCD) was more recently demonstrated able to achieve early detection of the children at high risk for clinical strokes. A randomized study demonstrated that a first stroke may be prevented by monthly transfusion in children with abnormal TCD, leading to a recommendation for annual TCD screening of children aged between 2 and 16 years and monthly transfusion for those with abnormal results. In children who have had a first stroke, the risk of recurrence is more than 50% and is greatly reduced by chronic transfusion, although not completely abolished. Hematopoietic stem cell transplant is indicated in children with cerebral vasculopathy who have an HLA-identical sibling.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Cytotoxic Edema: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Complications of Diabetes Mellitus
